attenuate 发表于 2025-3-25 06:08:22

http://reply.papertrans.cn/19/1802/180141/180141_21.png

Parameter 发表于 2025-3-25 10:42:19

http://reply.papertrans.cn/19/1802/180141/180141_22.png

散开 发表于 2025-3-25 12:27:47

http://reply.papertrans.cn/19/1802/180141/180141_23.png

harpsichord 发表于 2025-3-25 18:23:30

http://reply.papertrans.cn/19/1802/180141/180141_24.png

开始从未 发表于 2025-3-25 20:33:24

http://reply.papertrans.cn/19/1802/180141/180141_25.png

危险 发表于 2025-3-26 03:27:14

http://reply.papertrans.cn/19/1802/180141/180141_26.png

使绝缘 发表于 2025-3-26 05:30:21

http://reply.papertrans.cn/19/1802/180141/180141_27.png

Conscientious 发表于 2025-3-26 11:35:42

Parallel and Serial Blockade Strategies in BRAF-Mutant Melanoma,atalytic activity and its downstream effectors in the RAS-RAF-MEK-ERK signaling pathway. Both selective BRAF and MEK inhibitors have demonstrated high clinical response rates in metastatic melanoma patients with activating . mutations. These successes have illustrated several keys to the successful

抚慰 发表于 2025-3-26 16:25:59

http://reply.papertrans.cn/19/1802/180141/180141_29.png

Charade 发表于 2025-3-26 20:28:41

http://reply.papertrans.cn/19/1802/180141/180141_30.png
页: 1 2 [3] 4 5
查看完整版本: Titlebook: BRAF Targets in Melanoma; Biological Mechanism Ryan J. Sullivan Book 2015 Springer Science+Business Media New York 2015 BRAF-inhibitors.Nex